Concepedia

Katherine R. Singleton

KR

Statistics

Publications

13

Citations

1K

H-Index

12

Active since

2009

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Duke University

University of Colorado Denver

Cornell University

Massachusetts General Hospital

Katherine R. Singleton is an author at University of Colorado Anschutz Medical Campus specializing in medicine, molecular oncology, and oncology.

Publications per year

2009–2023

13

Publications

13

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 256 citations · Full text

, , +17

Systematic identification of signaling pathways with potential to confer anticancer drug resistance

Colin A. Martz, Kathleen Ottina, Katherine R. Singleton et al. · Science Signaling · 2014 · 199 citations

, , +17

Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence

Katherine R. Singleton, Lorin Crawford, Elizabeth Tsui et al. · Cell Reports · 2017 · 109 citations · Full text

, , +17

Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells

Marianne E. Marshall, Trista K. Hinz, Scott A. Kono et al. · Clinical Cancer Research · 2011 · 106 citations · Full text

, , +16

Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer

Kevin Lin, Justine C. Rutter, Abigail Xie et al. · Nature Genetics · 2020 · 90 citations

, , +16

1–5 of 13